It is generally accepted that the thymus-derived lymphocyte (T-cell) is the target cell for transformation by MDV. Evidence for this is mainly that MD lymphoblastoid cell lines are positive for T-cell antigens, when these cells are tested with antisera prepared against thymocytes (1-4), Using lactoperoxidase-catalyzed iodination techniques, Ross et al. (5), however, were unable to demonstrate the major thymus-specific polypeptide. It was not clear if this inability reflected technical problems or a real absence of this polypeptide. A more definitive description of the subset(s) of lymphocytes transformed by MDV has to await better defined reagents, Other antigens have been described on transformed cells, The major histocompatibility antigen defined by the B-locus and the minor histocompatibility C-antigen are present (6, 7) . A number of antigens not present on nontransformed lymphocytes can be detected on the surface of tumor cells. Powell et al.
(1) and later Witter et al. (8) described an MATSA, which could be distinguished from the major histocompatibility antigen (6) (7) (8) . In addition, Murthy et al. (9) demonstrated the presence of CFA on MD lymphoblastoid cell lines and on an AL V-transformed cell line. More recently, two antigens were shown on cell lines derived from jMV, a nonproducer MD transplant (10) , but not on other cell lines. Using monoclonal antibodies, Shearman et al. (14) and Schat et al. (15) demonstrated that the in vitro CMC against allogeneic MD tumor cells was not directed against MATSA but against an alloantigen also present on normal spleen cells with the same major histocompatibility complex as the tumor cell.
In other studies on the characterization of MDV -infected lymphocytes (Shek WR, Calnek BW, Schat KA, Chen CH: Submitted for publication), it was shown that the early lytic infection is initiated in vivo in a population of low-density lymphocytes that are positive for la, surface IgM, and Fe receptors. Later, other lymphocytes also became infected, Calnek et al. (16) corroborated these data by in vitro infection of splenic lymphocytes when they found that deletion of B-lymphocytes significantly reduced the extent of in vitro infection. In this paper, we characterize transformed lymphocytes by showing that they are low-density, Fe receptor-negative and fl-negative, but la-positive, cells.
MATERIALS AND METHODS
Experimental chickens and holding conditions.-Two specificpathogen-free departmental flocks were sources of experimental chickens: P-2 and the highly inbred UCD-003, which are homozygous for the major histocompatibility alleles Virus inoculation.-Passage 11 of the nononcogenic SB-l strain of MDV was propagated in chicken embryo fibro-ABBREVIATIONS USED: AbC=antibody-complement; ALV=avian leukosis virus; CFA=chicken fetal antigen; CMC=cell-mediated cytotoxicity; FITC=fluorescein isothiocyanate; HBSS-BSA=Hanks' balanced salt solution containing 1.5% bovine serum albumin and 0.1 % sodium azide; IFA=indirect fluorescent antibody; LM-20=RPMI-1640 medium with 20% heat-inactivated fetal bovine serum; MATSA=Marek's disease tumorassociated surface antigen; MD=Marek's disease; MDV=MD virus; NChS=normal chicken serum; REV=reticuloendotheliosis virus; SRBC=sheep red blood cell(s). 
blasts (22) . For the induction of cytotoxic spleen lymphocytes, 3-week-old UCD-003 chickens received SOO focusforming units of SB-I by intra-abdominal injection. Antisera and complement.-Ascitic fluids from BALB/c mice, inoculated with hybridomas secreting monoclonal antibodies against either the la-like (referred to in this paper as la) antigen of the chicken or the tt-chain of chicken IgM, were diluted 1: 100 and I :SO, respectively, in RPMI-1640 medium. Both monoclonal antibodies were prepared according to the method of Kearney et al. (23) . Anti-tt was induced by injection of purified IgM and characterized by radioimmunoassay against purified chicken immunoglobulins. This antibody gave staining patterns identical to those seen with highly purified goat anti-chicken tt (24) in doublefluorescence staining tests. The detailed characterization of anti-la, which is an IgM, will be published elsewhere (Ewert DL, Munchus MS, Chen CH, Cooper MD: Manuscript in preparation).
An alloantiserum against chicken Ia was from Dr. D. Gilmour (New York University, New York, N.Y.). B/L2 was prepared against B2 B2-linked la antigen (25) of chickens of lines 6 and 7. Anti-MATSA serum was prepared in rabbits by inoculation with MDCC-MSB-l cells (26) . Guinea pig serum was used as a source of complement. (27) . Twenty-four-well tissue culture plates (Falcon Plastics, Oxnard, Calif.) were used instead of 3S-mm tissue culture dishes; otherwise, the conditions were as described elsewhere (Shek WR, Calnek BW, Schat KA, Chen CH: Submitted for publication). Each cell line was tested by the addition of 2.SX 10 6 cells/well to two wells with anti-SRBC serum and to two wells with NChS. Normal spleen cells from 4-to 6-week-old chickens were included as a positive control in all tests. Adherence of cells to SRBC coated with NChS was considered as background, and specific adherence was calculated by the following formula: percent specific adherence = percent adherence to SRBC coated with anti-SRBC serum -percent adherence to SRBC coated with NChS.
IFA test.-Ia antigen and surface IgM were detected by IF A tests applied to all cell lines listed in table 1. One to two million cells were resuspended in HBSS-BSA, incubated at room temperature for 30 minutes, centrifuged, and resuspended in 20 ttl of monoclonal anti-Ia or anti-tt. After 30 minutes at 4°C, cells were washed once in HBSS-BSA, resuspended in 20 ttl of FITC-conjugated goat anti-mouse globulin serum (Cappel Laboratories, Cochranville, Pa.), and kept at 4°C for 30 minutes. Cells were washed once in HBSS-BSA and resuspended in 0.1 ml of HBSS-BSA. Smears of 10 ttl were air dried, either fixed with methanol for 4 minutes or left unfixed, rinsed in Tris-buffered saline, and then examined for membrane fluorescence with a Leitz Dialux fluorescence microscope equipped with epi-illumination. Normal splenic lymphocytes were included in each trial to assure that the test could detect cells positive for la antigen or JL-chain.
At least 200 cells were scored independently by two investigators for most trials. The presence of la was also investigated by staining MDCC-CU20 (B2 B2), , and MDCC-CU36 (B17B17) with the B/L2 alloantisera against la. The procedure was exactly as above except that FITC-conjugated horse anti-chicken globulin serum (Roboz Surgical Instrument Co., Inc., Washington, D.C.) was used for staining.
Blocking assays. The AbC lysis test was done as reported before (14) . Cells were incubated for 30 minutes with monoclonal antibody against la and washed. Complement was added. After incubation for 30 minutes at 39°C, the supernatants and the pellets were harvested separately and each was counted for 10 minutes in a Beckman 4000 gamma counter (Beckman Instruments, Inc., Irvine, Calif.). The procedure for the 4-hour CMC test has been reported (28) . Effector spleen cells were obtained from SB-1-inoculated or control UCD-003 chickens 7 days post inoculation. Effector cells were prepared by established procedures (14, 28) with one modification: Cells were separated on a Percoll three-step gradient to concentrate cytotoxic lymphocytes that have a density range of 1.057-1.068 glml (Schat KA: Unpublished data). A discontinuous gradient was made with 9.57 and 7.02% Percoll (Pharmacia Chemicals AB). Forty million cells in 11. 7% Percoll were carefully placed on the bottom, and the cells were centrifuged for 15 minutes at 400Xg. Cytotoxic lymphocytes were harvested from the interface formed between 9.57 and 7.02% Percoll. Target cells for the CMC test
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were reacted with monoclonal antibody against la antigen for 30 minutes just before the test or they were left untreated. Target and effector cells were resuspended for AbC and CMC assays in LM-20.
RESULTS

Isopyknic Separation of MD Lymphoblastoid Cell Lines
The results of the two trials are summarized in table 2. Most (78-91 %) of the tumor cells were found in fractions 3-5 (density, 1.051-1.060 g/ml) , whereas only 9-28% of normal spleen cells were in those same fractions. Small differences in density were observed between P-2-derived tumors and UCD-003-derived tumors; the density of the former was apparently slightly higher than that of the latter, since more of the cells were in the higher fractions. The same differences were observed between normal spleen cells obtained from UCD-003 and P-2 chicks. The densities of the Percoll in all recovered fractions were identical in both experiments.
Fc Receptors
In total, eight tests were done in which the following cell lines were tested for the presence of 
Presence of JL and la on Lymphoblastoid Cell lilies
IFA test: Normally, 30-40% of the spleen cells were positive for the presence of la, and 10-15% of the cells were positive for JL. The intensity of the staining for JL was weak, while the Ia stained intensively. On the one hand, all cell lines, including the avian leukosis cell line LSCC-CUI0 and the reticuloendotheliosis line RECC-UTl, were negative for Jl. On the other hand, all cell lines were pc,sitive for la with the exception ofMDCC-RPl and LSCC-CUlO. Between 70 and 100% of the cells showed either patchy or complete ring fluorescence. The intensity of the staining was generally quite strong, and cell clumping was occasionally observed. Most cell lines were tested between passage levels 10 and 35.
Exceptions were MDCC-CU 1 7, tested at passages 24 and 53; MDCC-MSB-l, tested at passages 116 and 342; and MDCC-RPl, tested at passage 204. There were no detectable differences between low-and high-passage levels of MDCC-MSB-l and MDCC-CU 17 when tested for the presence of Ia. ). Both intensity of staining and number of fluorescing cells were comparable to reactions with monoclonal anti-lao AbC lysis: Eight MD cell lines and RECC-UTI (table 3) were found to be positive for Ia with the use of an AbC lysis test. The percent release of 5ICr in the presence of anti-Ia and complement varied, but it was always considerably higher than the percent release with LM-20, anti-la, or complement. On occasion, the monoclonal anti-Ia seemed slightly toxic for certain cell lines. Interestingly, MDCC-RP 1 was positive for Ia in the AbC lysis test but not in the less sensitive IFA test. Ia could not be demonstrated on LSCC-CU 10, the AL V -induced cell line.
Blocking Assays
Treatment of MDCC-MSB-l with antiserum against MATSA did not block the staining of the cells with antiserum against la. The reverse was also true. Monoclonal antiIa did not block the staining of MDCC-MSB-l by MA TSA (table 4) .
Treatment of MDCC-CU20 with monoclonal anti-Ia did prevent the staining of the cells by alloantiserum. However, the alloantiserum did not prevent the recognition of the cells by the monoclonal antibody (table 4), as could be expected for two antibodies detecting a public and a private (allo-) antigenic determinant, respectively.
CMC Assays
In two trials MDCC-CU 12 cells were treated either with monoclonal anti-Ia or with LM-20. The coating with anti- Ia was effective since the addition of complement resulted in cytolysis (table 5) . A total of 10 of 15 SB-1-inoculated chickens yielded cytotoxic spleen cell preparations causing a significant percent specific release. The presence of anti-Ia on the surface of the target cells did not interfere with the percent specific release, nor did it change the percent release in the presence of lymphocytes from control birds.
DISCUSSION
An antigen comparable to the Ia antigen of the mouse and the human being has been detected on chicken B-cells (bursa-derived cells), monocytes, macrophages, and a small population of unidentified mononuclear cells prevalent in the spleen and bone marrow (29) . The la-like antigen of the chicken is closely linked with the B-major histocompatibility complex (30) . Recently, the Ia antigen has been reported to be present on important subsets of T-cells. Hammerling et al. (31) found that 40% of the T-cells of the mouse carried Ia antigens, but these antigens could be detected only with a fluorescein-activated cell sorter and not by conventional IFA staining or AbC cytotoxicity. These authors calculated that the density ofIa molecules on T-cells was a hundredfold less than that on B-cells. Enhanced expression of la on human T -cells has been reported for T-cell leukemias (32) and as a result of blast transformation by antigen and mitogen stimulation (33) .
The presence of la-like antigens was clearly demonstrated on all MD cell lines by IFA tests and/or complement lysis. The detection of la, as well as the absence of Fc receptors and IgM on the surface of the MD tumor cell lines, is compatible with the suggested T-cell nature of the MD tumor cells. In a recent paper, the question was raised whether la-positive T-cells of chickens might be suppressor cells (25), as is the case in the mouse (34) . It would be of considerable interest to search for suppressor factors produced by MD tumor cell lines. The densities of the cell lines examined in this study were comparable to those of the spleen cells that resulted in the establishment of cell lines (Shek WR: Unpublished data).
It is not clear from the data whether MDV-transformed lymphocytes express Ia antigen as a consequence of transformation or whether the expression of the Ia antigen is a prerequisite to infection and transformation. The prerequisite theory would present an attractive explanation for transformation. The finding of Ia on the tumor cells adds one more antigen to the growing list of antigens known to be present on such cells. It is unlikely that this antigen is identical to MATSA, CFA, Forssman antigen, or organ-specific metastasis antigen for the following reasons: 1) Anti-MATSA Surface Antigens on MD Cell Lines 719 serum failed to block staining of Ia. 2) CF A was found to be present on LSCC-CUlO (previously named TLT-1) (9), whereas we were unable to demonstrate Ia on this cell line. 3) Forssman antigen was found only on JMV-derived cell lines and not on MDCC-MSB-1 (/2), whereas Ia was present on all MD cell lines. Interestingly, Ia appeared to be present at a lower concentration on the JMV-derived cell line MDCC-RPI than on the other MD cell lines. 4) A number of the cell lines positive for Ia failed to transplant (35) , which makes it unlikely that Ia is related to an organ-specific metastasis antigen.
Recently, Schat et al. (15) showed that the allogeneic CMC against MD tumor cells was directed against alloantigens. They speculated that this could be against the major histocompatibility B-antigen or the Ia antigen. It now seems unlikely that the CMC was directed against Ia antigen. Coating of Ia with monoclonal antibody covered the public and private major histocompatibility complex-related antigen (blocking assay), but it did not prevent lysis of allogeneic target cells by effector cells.
The one-way blocking of Ia (table 4) by the monoclonal antibody to the reaction with the allo anti-Ia serum suggests that the determinants are situated close to each other; therefore, the large IgM molecules of the monoclonal antiIa may have physically blocked the attachment of the alloantiserum.
